| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.003 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |